查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1509672

医药品用明胶的全球市场的评估:各类型，来源，各用途，各功能，各终端用户，各地区，机会，预测(2017年～2031年)

Pharmaceutical Gelatin Market Assessment, By Type, By Source, By Application, By Function, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 228 Pages | 商品交期: 3-5个工作天内

价格

全球药用明胶市场规模预计将从 2023 年的 12.5 亿美元增至 2031 年的 19.2 亿美元，在 2024-2031 年预测期内复合年增长率预计为 5.57%。塑造市场的因素有很多。其中包括研究投资的增加、技术的进步、对猪肉明胶的高需求、明胶胶囊的日益普及、欧洲市场需求的增加以及寻求扩张机会的公司。

市场的关键驱动因素之一是研发策略投资的增加。这些策略有助于促进成长和增加产量所需的工业创新和技术进步。随着药物传输和基于明胶的治疗技术的进步，明胶正在寻找新的医学用途。对猪肉明胶的高需求也是全球药用明胶市场的主要成长动力。猪肉明胶的优良品质使其非常适合用于製药业。随着技术的进步，猪肉明胶的用途不断增加，这表明未来对该产品的需求将持续下去。

胶囊技术的进步，例如植物基明胶胶囊的诞生，提高了明胶胶囊的性能和适应性，使其对生产商和客户都更具吸引力。明胶胶囊在全球药用明胶市场的需求量很大，因为它们能够保护内容物免受空气、光线、微生物生长和污染的影响。欧洲市场也是全球市场的主要成长动力。随着欧盟 (EU) 医药市场的成长和医药产业的强劲，药用明胶变得越来越重要。

最后，公司正在寻求多样性和成长。新明胶品牌的推出以及现有品牌在新领域的发展清楚地证明了这一点。预计这些因素将在未来几年推动全球药用明胶市场的进一步成长和多元化。

例如，2024 年5 月，喀拉拉邦工业发展有限公司(KSIDC) 和日本Nitta Gelatin Inc. 日本透过Nitta Gelatin India Ltd (NGIL) 在喀拉拉邦联合启动了一个耗资718 万美元的扩建项目。该项目是喀拉拉邦首席部长最近访问日本期间这家日本跨国公司宣布的 2,396 万美元投资的一部分。

研究活动支持市场扩张

由于产业研发 (R&D) 活动的增加，全球药用明胶市场正在大规模扩张。製药公司投资数百万美元用于研发，以开发尖端的明胶产品，例如可生物降解胶囊和先进的药物传输系统。因此，新的明胶品牌和产品不断涌现，例如 X-Pure-GelDAT，它是 GelTYR-明胶酪胺的替代品。此外，明胶生产方法的发展预计将提高生产力和可用性，并推动全球药用明胶市场的扩张。

例如，2022 年 1 月，Darling Ingredients Inc. 透过其胶原蛋白解决方案的全球领导者 Rousselot Health 品牌与位于加州的再生医学研究所 Terasaki Institute for Biomedical Innovation (TBI) 合作。透过这个策略联盟，罗赛洛和 TIBI 将共同致力于明胶疗法的开发及其临床应用。罗赛洛将向 TIBI 提供 X-Pure 改性明胶，包括 X-Pure GelMA，以换取有关明胶如何透过实验室和临床试验发挥作用的资讯。

技术进步刺激市场成长

奈米技术、3D 列印、人工智慧和机器学习等技术进步正在推动全球药用明胶市场的成长。製药公司正在利用这些技术来生产新型明胶产品，其功能和品质超越了传统解决方案。这些技术使明胶产品的开发过程更具成本效益和效率。明胶也广泛应用于其他製药领域，如基因治疗、药物传输系统和组织工程。由于这些技术正在推动全球药用明胶市场的成长，明胶在製药业的使用预计将继续扩大。

本报告提供全球医药品用明胶市场相关调查分析，提供市场规模与预测，市场动态，主要企业的形势及预测等资讯。

目录

第1章 调查手法

第2章 计划的范围和定义

第3章 摘要整理

第4章 全球医药品用明胶市场预测(2017年～2031年)

  • 市场规模与预测
    • 金额
    • 数量
  • 各类型
    • A类型
    • B类型
  • 来源
    • 牛
    • 猪
    • 其他
  • 各用途
    • 硬明胶胶囊
    • 软体明胶胶囊
    • 其他
  • 各功能
    • 稳定化
    • 增加粘性
    • 凝胶化
    • 其他
  • 各终端用户
    • 製药企业
    • 生物科技企业
    • 学术·研究机关
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美
    • 中东·非洲
  • 市场占有率:各企业(2023年)

第5章 全球医药品用明胶市场预测:各地区(2017年～2031年)

  • 北美
    • 市场规模与预测
    • 各类型
    • 来源
    • 各用途
    • 各功能
    • 各终端用户
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 俄罗斯
    • 荷兰
    • 西班牙
    • 土耳其
    • 波兰
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳洲
    • 越南
    • 韩国
    • 印尼
    • 菲律宾
  • 南美
    • 巴西
    • 阿根廷
  • 中东·非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非

第6章 市场製图(2023年)

  • 各类型
  • 来源
  • 各用途
  • 各功能
  • 各终端用户
  • 各地区

第7章 宏观环境和产业结构

  • 供需分析
  • 进口出口分析
  • 价值链分析
  • PESTEL分析
  • 波特的五力分析

第8章 市场动态

  • 成长促进因素
  • 阻碍成长的要素(课题，阻碍因素)

第9章 法规结构和革新

  • 专利形势
  • 法规当局的认证
  • 革新/新技术

第10章 主要企业的形势

  • 市场领导者前五名公司的竞争矩阵
  • 市场领导者前五名公司的市场收益的分析(2023年)
  • 合併和收购/合资企业(如果适用)
  • SWOT分析(市场5企业)
  • 专利分析(如果适用)

第11章 价格分析

第12章 案例研究

第13章 主要企业预测

  • Gelita AG
  • Darling Ingredients Inc.
  • Nitta Gelatin, Inc.
  • Tessenderlo Group
  • Weishardt International
  • Lonza Group AG
  • Aspire Pharmaceuticals, Inc.
  • Junca Gelatines S.L
  • Gelco International
  • Trobas Gelatine BV

第14章 策略性推荐

第15章 本公司相关资料，免责声明

Product Code: MX11553

Global pharmaceutical gelatin market is projected to witness a CAGR of 5.57% during the forecast period 2024-2031F, growing from USD 1.25 billion in 2023 to USD 1.92 billion in 2031F. Various factors shape the global pharmaceutical gelatin market. These include increased investments in research, technological advancements, high demand for porcine gelatin, rise in the popularity of gelatin capsules, growing demand in the European market, and companies increasingly seeking expansion opportunities.

One significant driver of the global pharmaceutical gelatin market is the increased investment in research and development initiatives. These initiatives aid in promoting innovation and technological advancements in the industry, which is required for growth and increased production. Gelatin is finding new uses in pharmaceuticals thanks to technological developments in drug delivery and gelatin-based therapeutics. The high demand for porcine gelatin is another major factor driving the growth of the global pharmaceutical gelatin market. The superior qualities of porcine gelatin make it extremely desirable for use in the pharmaceutical industry. The applications of porcine gelatin are increasing with advancements in technologies, which indicates its continued demand for the product in the future.

Advancements are improving the performance and adaptability of gelatin capsules in capsule technology, such as the creation of plant-based gelatin capsules, which is increasing their appeal to both producers and customers. Gelatin capsules are in high demand in the global pharmaceutical gelatin market because of their ability to protect the contents from air, light, microbial growth and contamination. The European market is an additional significant factor boosting the growth of the global pharmaceutical gelatin market. Pharmaceutical gelatin is becoming more and more essential due to the European Union's growing pharmaceutical market and strong pharmaceutical sector.

Finally, businesses seek variety and growth. The introduction of new gelatin brands and the growth of established ones into new areas are clear indications of this. These factors are anticipated to fuel the further growth and diversification of the global pharmaceutical gelatin market in the upcoming years.

For example, in May 2024, the Kerala State Industrial Development Corporation Ltd (KSIDC) and Nitta Gelatin Inc. Japan jointly launched an expansion project in Kerala valued at USD 7.18 million through Nitta Gelatin India Ltd (NGIL). This project is a portion of the USD 23.96 million investment that the Japanese MNC disclosed during the Kerala Chief Minister's most recent visit to Japan.

Research Initiatives Propel the Expansion of the Market

Due to the industry's growing research and development (R&D) activities, the global pharmaceutical gelatin market is expanding significantly on a large scale. Pharmaceutical corporations are heavily spending on research and development to create cutting-edge gelatin-based products like biodegradable capsules and sophisticated drug delivery systems. New gelatin brands and products have emerged as a result, such as X-Pure-GelDAT, a substitute for GelTYR-Gelatin Tyramine. Furthermore, it is anticipated that developments in gelatin production methods will boost productivity and affordability, propelling the expansion of the global pharmaceutical gelatin market.

For example, in January 2022, Darling Ingredients Inc. established a partnership with the Terasaki Institute for Biomedical Innovation (TIBI), a regenerative medicine research institute situated in California, through its Rousselot Health brand, which is the world leader in collagen-based solutions. Rousselot and TIBI will work together on the creation of gelatin-based treatments and their clinical application through this strategic alliance. Rousselot will provide TIBI with X-Pure modified gelatins, including X-Pure GelMA, in exchange for information on how gelatin behaves in the laboratory and throughout clinical trials.

Technological Advancements Spur Growth of the Market

Advancements in technologies such as nanotechnology, 3D printing, artificial intelligence, and machine learning are propelling the growth of the global pharmaceutical gelatin market. Pharmaceutical companies are making use of these technologies to produce novel gelatin-based goods that surpass the functionality and quality of conventional solutions. These technologies have made the development process of gelatin-based products more cost-effective and efficient. Gelatin is also being extensively used in other pharmaceutical sectors such as gene therapy, drug delivery systems, and tissue engineering. The application of gelatin in the pharmaceutical industry will continue to expand due to these technologies propelling the growth of the global pharmaceutical gelatin market.

For example, in December 2023, the health brand Rousselot from Darling Ingredients Inc. announced that it had received US Patent and Trademark Office (USPTO) Patent No. US11795489B2, securing its intellectual property rights for StabiCaps, a specialized gelatin that enhances the stability and formulation of soft gel capsules to improve drugs' release.

High Demand for Porcine Gelatin Drives Market Growth

Due to the unique characteristics of gel-forming ability and the biocompatible nature of porcine gelatin, it is commonly used in the pharmaceutical industry, bolstering the growth of the global pharmaceutical gelatin market. Porcine gelatin is known for its clarity and flexibility, which makes it excessively useful in the manufacturing of hard gelatin capsules, and it also has other applications in the pharmaceutical industry, such as soft capsules, absorbable hemostats, etc. It is also used as a stabilizer in vaccines to preserve its efficacy and safety throughout the transit and storage process. Porcine gelatin is a preferred choice for pharmaceutical manufacturers because of its ease of production, nutritious content, and reduced cost.

For instance, to save production costs and waste related to soft gel leakers, Gelita AG, a global leader in gelatin, introduced Easyseal gelatin in December 2023. The novel solution can be obtained in swine form that complies with food and drug administration (FDA) requirements, and a corresponding China Drug Masterfile is available to facilitate entry into the Chinese market.

Rise in the Popularity of Gelatin Capsules Fuels Market Growth

There is a huge demand for gelatin capsules because of their versatility and ease of use. A significant demand for dietary supplements and nutraceuticals has been seen in the last few years, boosting the growth of gelatin capsules in the global pharmaceutical gelatin market. There is an increased demand for gelatin capsules made from alternative sources because of the rise in inclination towards vegan lifestyles and plant-based food. Gelatin capsules are becoming more customizable and effective due to technological and formulation advances, which appeal to both manufacturers and consumers.

In September 2023, Strides Pharma Science Limited declared that the United States Food and Drug Administration (USFDA) has approved Icosapent Ethyl Capsules, 0.5 gram and 1 gram, through its step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore. The product enhances the selection of authorized soft gelatin capsules offered by Strides.

Europe Shows Dominance in the Pharmaceutical Gelatin Market

Europe's pharmaceutical gelatin market has observed significant growth over the past couple of years. Companies are focusing on producing new products through research and development to cater to the growing demand that has arisen because of the growing burden of chronic diseases and the rise in the geriatric population. The global pharmaceutical gelatin market participants focus on continuous clinical trials to improve the efficacy of the medications. The global pharmaceutical gelatin market is expanding due to pharmaceutical companies and concerned authorities meeting patient requirements, surpassing challenges such as the limitations of sustainability and ethical concerns.

For example, Caldic B.V. and Nitta Gelatin, Inc. announced that they had reached an agreement to form a strategic distribution relationship in Europe. Through this partnership, Caldic will be able to provide a greater selection of specialty gelatin products and a broad range of collagen products that perfectly match its current line of products for the Food, Nutrition, Pharma, and Personal Care markets. Starting on January 1, 2024, Caldic and Nitta Gelatin collaborated to create prospects in Benelux, France, Iberia, Italy, Germany, Austria, Switzerland, United Kingdom, and Ireland.

Future Market Scenario (2024-2031F)

The significant shift toward biodegradable gelatin capsules is considered a major factor driving the growth of the global pharmaceutical gelatin market in the future.

The global pharmaceutical gelatin market will witness a significant rise in the use of gelatin in the functional food industry.

Advanced technologies like nanotechnology and 3D printing are going to drive the global pharmaceutical gelatin market. These technologies are used to produce innovative gelatin products with enhanced properties.

An increased use of gelatin in cosmetics and personal care products is expected to significantly drive the growth of the global pharmaceutical gelatin market.

Key Players Landscape and Outlook

One of the main factors driving the expansion of the global pharmaceutical gelatin market is partnerships and collaborations. These partnerships guarantee that many viewpoints are considered to meet the needs of a diversified nature. Through successful collaborations, companies in the industry share their expertise in developing new and innovative solutions, increasing efficiency, and reducing costs. Companies also often collaborate to increase their expansion in the global pharmaceutical gelatin market and reach new customers.

For example, in March 2024, BIO INX B.V., a leading material developer for 3D bioprinting, announced a strategic relationship with Rousselot GmbH, a global leader in gelatin- and collagen-based solutions included in Darling Ingredients Inc. This partnership represents a significant advancement in the field of 3D bioprinting. As part of this partnership, Rousselot's X-Pure gelatin biomaterials, which are known for their dependability and quality, will be distributed by BIO INX for research and technical purposes.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Pharmaceutical Gelatin Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Type
    • 4.2.1. Type A
    • 4.2.2. Type B
  • 4.3. By Source
    • 4.3.1. Bovine
    • 4.3.2. Porcine
    • 4.3.3. Others
  • 4.4. By Application
    • 4.4.1. Hard Gelatin Capsules
    • 4.4.2. Soft Gelatin Capsules
    • 4.4.3. Others
  • 4.5. By Function
    • 4.5.1. Stabilizing
    • 4.5.2. Thickening
    • 4.5.3. Gelling
    • 4.5.4. Others
  • 4.6. By End-user
    • 4.6.1. Pharmaceutical Companies
    • 4.6.2. Biotechnology Companies
    • 4.6.3. Academic and Research Institutions
  • 4.7. By Region
    • 4.7.1. North America
    • 4.7.2. Europe
    • 4.7.3. Asia-Pacific
    • 4.7.4. South America
    • 4.7.5. Middle East and Africa
  • 4.8. By Company Market Share (%), 2023

5. Global Pharmaceutical Gelatin Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Type
      • 5.1.2.1. Type A
      • 5.1.2.2. Type B
    • 5.1.3. By Source
      • 5.1.3.1. Bovine
      • 5.1.3.2. Porcine
      • 5.1.3.3. Others
    • 5.1.4. By Application
      • 5.1.4.1. Hard Gelatin Capsules
      • 5.1.4.2. Soft Gelatin Capsules
      • 5.1.4.3. Others
    • 5.1.5. By Function
      • 5.1.5.1. Stabilizing
      • 5.1.5.2. Thickening
      • 5.1.5.3. Gelling
      • 5.1.5.4. Others
    • 5.1.6. By End-user
      • 5.1.6.1. Pharmaceutical Companies
      • 5.1.6.2. Biotechnology Companies
      • 5.1.6.3. Academic and Research Institutions
    • 5.1.7. United States*
      • 5.1.7.1. Market Size & Forecast
        • 5.1.7.1.1. By Value
        • 5.1.7.1.2. By Volume
      • 5.1.7.2. By Type
        • 5.1.7.2.1. Type A
        • 5.1.7.2.2. Type B
      • 5.1.7.3. By Source
        • 5.1.7.3.1. Bovine
        • 5.1.7.3.2. Porcine
        • 5.1.7.3.3. Others
      • 5.1.7.4. By Application
        • 5.1.7.4.1. Hard Gelatin Capsules
        • 5.1.7.4.2. Soft Gelatin Capsules
        • 5.1.7.4.3. Others
      • 5.1.7.5. By Function
        • 5.1.7.5.1. Stabilizing
        • 5.1.7.5.2. Thickening
        • 5.1.7.5.3. Gelling
        • 5.1.7.5.4. Others
      • 5.1.7.6. By End-user
        • 5.1.7.6.1. Pharmaceutical Companies
        • 5.1.7.6.2. Biotechnology Companies
        • 5.1.7.6.3. Academic and Research Institutions
    • 5.1.8. Canada
    • 5.1.9. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Type
  • 6.2. By Source
  • 6.3. By Application
  • 6.4. By Function
  • 6.5. By End-user
  • 6.6. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Gelita AG
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Darling Ingredients Inc.
  • 13.3. Nitta Gelatin, Inc.
  • 13.4. Tessenderlo Group
  • 13.5. Weishardt International
  • 13.6. Lonza Group AG
  • 13.7. Aspire Pharmaceuticals, Inc.
  • 13.8. Junca Gelatines S.L
  • 13.9. Gelco International
  • 13.10. Trobas Gelatine BV

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 3. Global Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 4. Global Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 5. Global Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 7. Global Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 8. Global Pharmaceutical Gelatin Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 11. North America Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 12. North America Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 13. North America Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 14. North America Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 15. North America Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 16. North America Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 19. United States Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 20. United States Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 21. United States Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 22. United States Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 23. United States Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 24. Canada Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 26. Canada Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 27. Canada Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 28. Canada Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 29. Canada Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 30. Canada Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 31. Mexico Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 33. Mexico Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 34. Mexico Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 35. Mexico Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 36. Mexico Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 37. Mexico Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 38. Europe Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 40. Europe Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 41. Europe Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 42. Europe Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 43. Europe Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 44. Europe Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 45. Europe Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 48. Germany Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 49. Germany Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 50. Germany Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 51. Germany Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 52. Germany Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 53. France Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 55. France Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 56. France Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 57. France Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 58. France Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 59. France Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 60. Italy Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 62. Italy Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 63. Italy Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 64. Italy Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 65. Italy Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 66. Italy Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 67. United Kingdom Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 69. United Kingdom Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 70. United Kingdom Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 71. United Kingdom Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 72. United Kingdom Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 73. United Kingdom Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 74. Russia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 76. Russia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 77. Russia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 78. Russia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 79. Russia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 80. Russia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 81. Netherlands Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Netherlands Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 83. Netherlands Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 84. Netherlands Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 85. Netherlands Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 86. Netherlands Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 87. Netherlands Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 88. Spain Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Spain Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 90. Spain Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 91. Spain Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 92. Spain Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 93. Spain Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 94. Spain Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 95. Turkey Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Turkey Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 97. Turkey Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 98. Turkey Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 99. Turkey Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 100. Turkey Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 101. Turkey Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 102. Poland Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. Poland Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 104. Poland Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 105. Poland Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 106. Poland Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 107. Poland Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 108. Poland Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 109. South America Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. South America Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 111. South America Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 112. South America Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 113. South America Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 114. South America Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 115. South America Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 116. South America Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Brazil Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 119. Brazil Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 120. Brazil Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 121. Brazil Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 122. Brazil Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 123. Brazil Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 124. Argentina Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Argentina Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 126. Argentina Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 127. Argentina Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 128. Argentina Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 129. Argentina Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 130. Argentina Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 131. Asia-Pacific Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Asia-Pacific Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 133. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 134. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 135. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 136. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 137. Asia- Pacific Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 138. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
  • Figure 139. India Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. India Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 141. India Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 142. India Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 143. India Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 144. India Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 145. India Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 146. China Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 147. China Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 148. China Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 149. China Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 150. China Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 151. China Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 152. China Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 153. Japan Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 154. Japan Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 155. Japan Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 156. Japan Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 157. Japan Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 158. Japan Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 159. Japan Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 160. Australia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 161. Australia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 162. Australia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 163. Australia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 164. Australia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 165. Australia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 166. Australia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 167. Vietnam Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Vietnam Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 169. Vietnam Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 170. Vietnam Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 171. Vietnam Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 172. Vietnam Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 173. Vietnam Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 174. South Korea Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 175. South Korea Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 176. South Korea Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 177. South Korea Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 178. South Korea Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 179. South Korea Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 180. South Korea Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 181. Indonesia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. Indonesia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 183. Indonesia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 184. Indonesia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 185. Indonesia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 186. Indonesia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 187. Indonesia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 188. Philippines Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 189. Philippines Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 190. Philippines Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 191. Philippines Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 192. Philippines Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 193. Philippines Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 194. Philippines Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 195. Middle East & Africa Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Middle East & Africa Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 197. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 198. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 199. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 200. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 201. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 202. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 204. Saudi Arabia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 205. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 206. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 207. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 208. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 209. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 210. UAE Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 211. UAE Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 212. UAE Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 213. UAE Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 214. UAE Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 215. UAE Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 216. UAE Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 217. South Africa Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
  • Figure 218. South Africa Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
  • Figure 219. South Africa Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
  • Figure 220. South Africa Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
  • Figure 221. South Africa Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
  • Figure 222. South Africa Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
  • Figure 223. South Africa Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
  • Figure 224. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225. By Source Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Function Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By End-User Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023